Schütt C - Search Results

1

Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism.

Grunwald U, Fan X, Jack RS, Workalemahu G, Kallies A, Stelter F, Schütt C. Grunwald U, et al. Among authors: schutt c. J Immunol. 1996 Nov 1;157(9):4119-25. J Immunol. 1996. PMID: 8892647

2

Neutrophil influx in response to a peritoneal infection with Salmonella is delayed in lipopolysaccharide-binding protein or CD14-deficient mice.

Yang KK, Dorner BG, Merkel U, Ryffel B, Schütt C, Golenbock D, Freeman MW, Jack RS. Yang KK, et al. Among authors: schutt c. J Immunol. 2002 Oct 15;169(8):4475-80. doi: 10.4049/jimmunol.169.8.4475. J Immunol. 2002. PMID: 12370383

3

Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria.

Jack RS, Grunwald U, Stelter F, Workalemahu G, Schütt C. Jack RS, et al. Among authors: schutt c. Eur J Immunol. 1995 May;25(5):1436-41. doi: 10.1002/eji.1830250545. Eur J Immunol. 1995. PMID: 7539760

4

Modalities of endotoxin binding to CD14.

Schütt C, Schilling T, Stelter F, Fürll B, Krüger C, Witt S, Jack R, Grunwald U. Schütt C, et al. Prog Clin Biol Res. 1995;392:339-48. Prog Clin Biol Res. 1995. PMID: 8524939 No abstract available.

5

Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14.

Schütt C, Schilling T, Grunwald U, Stelter F, Witt S, Krüger C, Jack RS. Schütt C, et al. Res Immunol. 1995 Jul-Aug;146(6):339-50. doi: 10.1016/0923-2494(96)81038-8. Res Immunol. 1995. PMID: 8719658

6

Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli.

Stelter F, Bernheiden M, Menzel R, Jack RS, Witt S, Fan X, Pfister M, Schütt C. Stelter F, et al. Among authors: schutt c. Eur J Biochem. 1997 Jan 15;243(1-2):100-9. doi: 10.1111/j.1432-1033.1997.00100.x. Eur J Biochem. 1997. PMID: 9030727 Free article.

7

Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection.

Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Fürll B, Freudenberg M, Schmitz G, Stelter F, Schütt C. Jack RS, et al. Among authors: schutt c. Nature. 1997 Oct 16;389(6652):742-5. doi: 10.1038/39622. Nature. 1997. PMID: 9338787

8

The molecular basis for therapeutic concepts utilizing CD14.

Stelter F, Bernheiden M, Menzel R, Witt S, Jack RS, Grunwald U, Fan X, Schütt C. Stelter F, et al. Among authors: schutt c. Prog Clin Biol Res. 1998;397:301-13. Prog Clin Biol Res. 1998. PMID: 9575571

9

Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction.

Fan X, Stelter F, Menzel R, Jack R, Spreitzer I, Hartung T, Schütt C. Fan X, et al. Among authors: schutt c. Infect Immun. 1999 Jun;67(6):2964-8. doi: 10.1128/IAI.67.6.2964-2968.1999. Infect Immun. 1999. PMID: 10338506 Free PMC article.

10

Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide.

Stelter F, Loppnow H, Menzel R, Grunwald U, Bernheiden M, Jack RS, Ulmer AJ, Schütt C. Stelter F, et al. Among authors: schutt c. J Immunol. 1999 Dec 1;163(11):6035-44. J Immunol. 1999. PMID: 10570291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters